Literature DB >> 7841301

Soluble urokinase receptor from fibrosarcoma HT-1080 cells.

H K Lau1, M Kim.   

Abstract

A soluble form of urokinase-binding protein has been isolated from the human fibrosarcoma cell line HT-1080 and cell lines derived from it. Conditioned media of these cells were collected after overnight incubation under serum-free conditions, and were concentrated and passed through a column of Sepharose 4B to which high-molecular-weight urokinase had been attached. After thorough washing, a polypeptide could be eluted from the column with 1 M acetic acid. This material appeared to be a single band of approximately 60 kDa on SDS polyacrylamide gel. It cross-reacted with commercial antibodies made against urokinase receptor, and could be chemically cross-linked to the amino terminal fragment of urokinase. This material was similar to the urokinase receptor that was cleaved from HT-1080 cells by means of phosphatidylinositol-specific phospholipase C.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7841301

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  4 in total

1.  Increase of a urokinase receptor-related low-molecular-weight molecule in colorectal adenocarcinomas.

Authors:  H K Lau; M Kim; J Koo; B Chiu; D Murray
Journal:  Clin Exp Metastasis       Date:  1995-11       Impact factor: 5.150

2.  Soluble urokinase receptor released from human carcinoma cells: a plasma parameter for xenograft tumour studies.

Authors:  C Holst-Hansen; M J Hamers; B E Johannessen; N Brünner; R W Stephens
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

Review 3.  Relating GPI-Anchored Ly6 Proteins uPAR and CD59 to Viral Infection.

Authors:  Jingyou Yu; Vaibhav Murthy; Shan-Lu Liu
Journal:  Viruses       Date:  2019-11-14       Impact factor: 5.048

Review 4.  Role of urokinase receptor in tumor progression and development.

Authors:  Hyangsoon Noh; Sungguan Hong; Shuang Huang
Journal:  Theranostics       Date:  2013-06-25       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.